This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2vti
From Proteopedia
| Line 1: | Line 1: | ||
| - | + | {{Seed}} | |
| + | [[Image:2vti.jpg|left|200px]] | ||
| - | The | + | <!-- |
| + | The line below this paragraph, containing "STRUCTURE_2vti", creates the "Structure Box" on the page. | ||
| + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| + | or leave the SCENE parameter empty for the default display. | ||
| + | --> | ||
| + | {{STRUCTURE_2vti| PDB=2vti | SCENE= }} | ||
| - | + | ===IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.=== | |
| - | Description: Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | ==About this Structure== |
| + | 2VTI is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VTI OCA]. | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Single protein]] | ||
| + | [[Category: Berdini, V.]] | ||
| + | [[Category: Boulstridge, J A.]] | ||
| + | [[Category: Brien, M A.O.]] | ||
| + | [[Category: Carr, M G.]] | ||
| + | [[Category: Cross, D M.]] | ||
| + | [[Category: Danillon, D.]] | ||
| + | [[Category: Davis, D J.]] | ||
| + | [[Category: Devine, L A.]] | ||
| + | [[Category: Early, T R.]] | ||
| + | [[Category: Feltell, R E.]] | ||
| + | [[Category: Lewis, E J.]] | ||
| + | [[Category: Mcmenamin, R L.]] | ||
| + | [[Category: Navarro, E F.]] | ||
| + | [[Category: Reilly, M O.]] | ||
| + | [[Category: Reule, M.]] | ||
| + | [[Category: Saxty, G.]] | ||
| + | [[Category: Seavers, L C.A.]] | ||
| + | [[Category: Smith, D M.]] | ||
| + | [[Category: Squires, M S.]] | ||
| + | [[Category: Trewartha, G.]] | ||
| + | [[Category: Walker, M T.]] | ||
| + | [[Category: Woodhead, A J.]] | ||
| + | [[Category: Woolford, A J.A.]] | ||
| + | [[Category: Wyatt, P G.]] | ||
| + | [[Category: Atp-binding]] | ||
| + | [[Category: Cell cycle]] | ||
| + | [[Category: Cell division]] | ||
| + | [[Category: Fragment screening]] | ||
| + | [[Category: Kinase]] | ||
| + | [[Category: Mitosis]] | ||
| + | [[Category: Nucleotide-binding]] | ||
| + | [[Category: Phosphoprotein]] | ||
| + | [[Category: Phosphorylation]] | ||
| + | [[Category: Polymorphism]] | ||
| + | [[Category: Protein kinase]] | ||
| + | [[Category: Serine/threonine protein kinase]] | ||
| + | [[Category: Serine/threonine-protein kinase]] | ||
| + | [[Category: Structure based drug design]] | ||
| + | [[Category: Transferase]] | ||
| + | |||
| + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Aug 6 12:50:24 2008'' | ||
Revision as of 09:50, 6 August 2008
IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
About this Structure
2VTI is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Page seeded by OCA on Wed Aug 6 12:50:24 2008
Categories: Homo sapiens | Single protein | Berdini, V. | Boulstridge, J A. | Brien, M A.O. | Carr, M G. | Cross, D M. | Danillon, D. | Davis, D J. | Devine, L A. | Early, T R. | Feltell, R E. | Lewis, E J. | Mcmenamin, R L. | Navarro, E F. | Reilly, M O. | Reule, M. | Saxty, G. | Seavers, L C.A. | Smith, D M. | Squires, M S. | Trewartha, G. | Walker, M T. | Woodhead, A J. | Woolford, A J.A. | Wyatt, P G. | Atp-binding | Cell cycle | Cell division | Fragment screening | Kinase | Mitosis | Nucleotide-binding | Phosphoprotein | Phosphorylation | Polymorphism | Protein kinase | Serine/threonine protein kinase | Serine/threonine-protein kinase | Structure based drug design | Transferase
